CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer-Reference-Cited by-同舟云学术

CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer

Published:2007-09-28 Issue:12 Volume:20 Page:1286-1297
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Liu Qiang,Teh Ming,Ito Kosei,Shah Nilesh,Ito Yoshiaki,Yeoh Khay Guan

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/3800968.pdf

Reference44 articles.

1. Correa P . Human gastric carcinogenesis: a multistep and multifactorial process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735–6740.

2. Meining A, Morgner A, Miehlke S, et al. Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely a hypothesis? Best Pract Res Clin Gastroenterol 2001;15:983–998.

3. Hattori T . Development of adenocarcinomas in the stomach. Cancer 1986;57:1528–1534.

4. Yuasa Y . Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer 2003;3:592–600.

5. Filipe MI, Potet F, Bogomoletz WV, et al. Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres. Gut 1985;26:1319–1326.

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modified Chaishao Liujunzi Decoction inhibits bile acid-induced gastric intestinal metaplasia: from network prediction to experimental verification;Aging;2023-12-10

2. Gastric Intestinal Metaplasia: Real Culprit or Innocent Bystander as a Precancerous Condition for Gastric Cancer?;Gastroenterology;2023-12

3. CAUDAL TYPE HOMEOBOX 2 EXPRESSION AND PROGNOSTIC FACTORS IN PATIENTS WITH GASTRIC ADENOCARCINOMA;THE NEW ARMENIAN MEDICAL JOURNAL;2023-09-05

4. Resveratrol induces the growth inhibition of CDX-deficient gastric cancer cells using CDX2 and RUNX3 via the β-catenin/TCF4 signaling pathway;Translational Oncology;2023-09

5. Chromosome 13;Cancer Genes: Volume 2;2023-08-16